J Sainsbury PLC (SBRY)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 358.80 |
|---|---|
| 52-week range | 285.86 – 380.30 |
| Return, 1 month / 3 months | +7.1% / +1.5% |
| Return, 1 year / 3 years | +15.1% / +67.9% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 21.8% |
| Worst drawdown (1 year) | -17.6% |
| Average daily value traded | 2,813.88M GBX |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
J Sainsbury is a British grocery and general merchandise retailer based in London. Through its supermarket stores and convenience shops, it sells food, drink, household goods and clothing to shoppers across the United Kingdom. The company also runs the Argos retail business and offers banking products through Sainsbury's Bank, serving customers who want everyday groceries, home items and financial services in one place.
J Sainsbury PLC trades under the code SBRY on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
J Sainsbury PLC (SBRY) trades on the London Exchange in UK. It last closed at GBX 358.80 on 19 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 268 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.1% and over the last three months it rose 1.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.6% | ||
| From 52-week high | -0.2% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.5% | ||
| 6-month return | 5.5% | ||
| 12-month return, skipping the last month | 7.4% | ||
| Risk (lower is better) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 21.8% | ||
| Worst drawdown (1 year) | -17.6% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 2,813.88M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +6.1% |
|---|---|
| 1 month | +7.1% |
| 3 months | +1.5% |
| 6 months | +5.5% |
| 1 year | +15.1% |
| 3 years | +67.9% |
| 5 years | +60.6% |
Signals
| 50-day / 200-day average | 336.56 / 327.40 |
|---|---|
| Golden / death cross (60 days) | Golden, 58 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.17 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | GBP 0.0960 |
| 13 Nov 2025 | GBP 0.1510 |
| 5 Jun 2025 | GBP 0.0970 |
| 14 Nov 2024 | GBP 0.0390 |
| 6 Jun 2024 | GBP 0.0920 |
| 9 Nov 2023 | GBP 0.0390 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.